| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/16/2009 | EP2100615A1 Cancer therapy |
| 09/16/2009 | EP2099497A2 Enhanced retinal delivery of a nucleic acid through iontophoresis |
| 09/16/2009 | EP2099496A2 Delivery of nanoparticles and/or agents to cells |
| 09/16/2009 | EP2099472A2 Intra-vascular kidney gene therapy with plasmid encoding bmp-7 |
| 09/16/2009 | EP2099438A2 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 09/16/2009 | EP1625395B1 Method for identifying tff2 regulating agents |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1463836B1 Vector mediated organelle transfection |
| 09/16/2009 | EP1414948B1 Inhibition of apoptosis process and improvement of cell performance |
| 09/16/2009 | EP1379273B1 Nucleic acid adjuvants |
| 09/16/2009 | EP1349568B1 Immunomodulatory constructs and their uses |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | CN101532030A Recombinant influenza virus vector carrying foreign genes in NA segment and preparation method and application thereof |
| 09/16/2009 | CN101532027A Hypoxia inducible eukaryotic gene expression vector and application thereof |
| 09/16/2009 | CN101532024A New type cell special gene HAAVmir containing microRNA combined sequence for gene treating |
| 09/16/2009 | CN101532019A Core fragment of human ZHX2 transcription factor and application thereof |
| 09/16/2009 | CN101532013A RNA for inhibiting Hepcidin, recombinant and application |
| 09/16/2009 | CN100540059C Rotavirus gene vaccine based on NSP4 gene |
| 09/16/2009 | CN100540058C Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 09/15/2009 | US7589191 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589174 GRP94-based compositions and methods of use thereof |
| 09/15/2009 | US7589071 increasing hemaglobin production in a mammalian cell in vitro; introducing a heterologous polynucleotide using the vector into cell by culturing; treating HIV/AIDS viral infection |
| 09/15/2009 | US7589070 Surface modification for improving biocompatibility |
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588914 Bacterial Bcl-2 domain-containing polypeptides, encoding nucleic acid molecules, and related methods |
| 09/15/2009 | US7588771 anticancer treatment by administering a recombinant vaccina virus of a modified TK thymidine kinase and HA hemagglutinin gene; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
| 09/15/2009 | US7588767 Recombinant vaccina virus of a modified TK and HA gene and optionally a modified F3 gene or locus; virus does not accumulate to toxic levels in non-targeted organs |
| 09/15/2009 | US7588758 A genetic vector comprising a promoter linked to an expression cassette able to express a cyclooxygenase protein; treating bone disorder osteoporosis, heterotopic ossification |
| 09/15/2009 | US7588757 Methods of treating Parkinson's disease using recombinant adeno-associated virus virions |
| 09/15/2009 | US7588756 Administering intracoronally a compatible auxiliary or support and a nucleic acid encoding a polypeptide S100A1 protein; increases the systolic Ca2+ release from the sarcoplasmic reticulum and increases the rate of Ca2+ uptake into the sarcoplasmic reticulum |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2204433C Use of neurite localized mrnas for medical diagnosis and therapeutics |
| 09/15/2009 | CA2195396C Genetic diagnosis of prostate cancer |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/14/2009 | CA2625811A1 Microrna mediated oncolytic targeting |
| 09/11/2009 | WO2009111755A2 Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein |
| 09/11/2009 | WO2009111701A2 Method of treating t cell mediated disorders |
| 09/11/2009 | WO2009111658A2 Compositions and methods for inhibiting expression of eg5 and vegf genes |
| 09/11/2009 | WO2009111169A2 Compositions comprising pkc-delta modulators and methods for ocular neuroprotection |
| 09/11/2009 | WO2009110324A1 Method for regulation of expression of low-density lipoprotein receptor, and enhancer of expression of low-density lipoprotein receptor |
| 09/11/2009 | WO2009109996A2 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination |
| 09/11/2009 | WO2009109862A2 Improved cancer therapeutics |
| 09/11/2009 | WO2009091815A3 Methods for modulating de novo hepatic lipogenesis by modulating xbp-1 activity |
| 09/11/2009 | WO2009088849A3 Treatment or prevention of inflammation by targeting cyclin d1 |
| 09/11/2009 | WO2009086000A3 Biomarkers for trichogenicity |
| 09/11/2009 | CA2716793A1 Compositions and methods for inhibiting expression of eg5 and vegf genes |
| 09/10/2009 | US20090229015 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto |
| 09/10/2009 | US20090228998 Induction of exon skipping in eukaryotic cells |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227660 GLP-1 gene delivery for the treatment of type 2 diabetes |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227656 Methods for using modulators of proline-rich tyrosine kinase 2 |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090227000 Chimeric adenoviruses for use in cancer treatment |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226505 NELL Peptide Expression Systems and Bone Formation Activity of NELL Peptide |
| 09/10/2009 | US20090226478 Early detection of flaviviruses using the NS1 glycoprotein |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226444 Pharmaceutical antibody compositions with resistance to soluble cea |
| 09/10/2009 | US20090226427 Novel pharmaceutical compositions for modulating angiogenesis |
| 09/10/2009 | US20090226425 Diagnostics and Therapeutics For Glaucoma |
| 09/10/2009 | US20090226416 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 09/09/2009 | EP2098595A1 Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 09/09/2009 | EP2098593A1 hTERT expression regulatory gene |
| 09/09/2009 | EP2097517A2 Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
| 09/09/2009 | EP2097453A2 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii) |
| 09/09/2009 | EP2097110A2 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 09/09/2009 | EP2097095A2 Myostatin inhibition for enhancing muscle and/or improving muscle function |
| 09/09/2009 | EP1802653B1 Mam domain containing protein |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/09/2009 | CN101529252A Aptamers directed to MUC1 |
| 09/09/2009 | CN101525626A Expression vector containing IER5 gene, monoclonal cell line and application thereof |
| 09/09/2009 | CN101525625A Clone, expression and application of mutase gene in Schistosoma japonicum phosphoglyceric acid |
| 09/09/2009 | CN101524548A Nanometer carrier combination and application thereof to preparation of anti-tumor drug |
| 09/09/2009 | CN101524547A DNA vaccine for preventing and treating cysticercosis cellulosae and preparation method thereof |
| 09/09/2009 | CN101524532A Single dose of a mycoplasma hyopneumoniae vaccine |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN101524529A Treatment on human malignant solid tumor by HNF4 alpha inducement and differentiation |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100536924C Method for preparing drug administration carrier of gene with polyethylene imine beautify chitosan |
| 09/09/2009 | CN100536923C Method for expressing human insulin for reducing blood sugar by transgenic lucid ganoderma |
| 09/08/2009 | US7585969 MicroRNA and methods for inhibiting same |
| 09/08/2009 | US7585967 DNA or RNA having a modified backbone or base and a section that hybridizes to an EphrinB2 or EphB4 transcript causing gene expression inhibition; antineoplastic and antiproliferative agents can be synergistically administered with a second agent |
| 09/08/2009 | US7585966 Directed against accessible regions in the telomerase ribonucleoprotein; cancer |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |